Dr. Seoyoung Kim, MD

• Rheumatology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Albert-ludwigs- University / Medical College

  Medical School, 2000

• Serious infection incidence rates in pediatric systemic lupus erythematosus according to medication use, 2014-09-18

• SGLT2 Inhibitors and the Risk of Acute Kidney Injury in Older Adults With Type 2 Diabetes, 2021-11-08

• Uptake of the First Biosimilar Infliximab since its Approval in South Korea, 2016-01-31

• Assessment for Perioperative Hyperglycemia Prior to Total Joint Replacement in Patients With and Without Diabetes Assessment for Perioperative Hyperglycemia Prior to Total Joint Replacement, 2019-09-04

• Sociodemographic, Disease, Health System, and Contextual Factors Affecting the Initiation of Biologic Agents in Rheumatoid Arthritis: A Longitudinal Study, 2014-07-08

• Bisphosphonates and Risk of Cardiovascular Events: A Meta-Analysis, 2015-04-17

• An external validation study reporting poor correlation between the claims-based index for rheumatoid arthritis severity and the disease activity score, 2015-04-13

• Severe Cutaneous Reactions requiring Hospitalization in Allopurinol Initiators: a Population-based Cohort Study, 2012-08-06

• Medication Burden and Prescribing Patterns in Patients on Hemodialysis in the USA, 2013-2017, 2021-11-23

• Disease modifying anti-rheumatic drug use and the risk of incident hyperlipidemia in patients with early rheumatoid arthritis: A retrospective cohort study, 2016-02-01

• Human Papillomavirus Vaccine Uptake among Individuals with Systemic Inflammatory Diseases, 2015-02-18

• Impact of the US Food and Drug Administration's safety-related announcements on the use of bisphosphonates after hip fracture, 2016-03-31

• Comparative Risk of Alzheimer Disease and Related Dementia Among Medicare Beneficiaries With Rheumatoid Arthritis Treated With Targeted Disease-Modifying Antirheumatic Agents Alzheimer Disease and Related Dementia Among Patients Treated With Targeted Disease-Modifying Antirheumatic Agents, 2022-04-08

• Patterns of health care utilization related to initiation of amitriptyline, duloxetine, gabapentin, or pregabalin in fibromyalgia, 2015-01-28

• Association of sodium-glucose cotransporter-2 inhibitors with incident atrial fibrillation in older adults with type 2 diabetes, 2022-10-03

• Bisphosphonates and Risk of Subtrochanteric, Femoral Shaft, and Atypical Femur Fracture: A Systematic Review and Meta-analysis, 2013-03-18

• Gout: a review of non-modifiable and modifiable risk factors, 2014-09-02

• Fracture risk after bariatric surgery: Roux-en-Y gastric bypass versus adjustable gastric banding, 2017-03-20

• Risk of Incident Atrial Fibrillation With Zoledronic Acid Versus Denosumab: A Propensity Score-Matched Cohort Study, 2020-11-02

• Association of Sodium-Glucose Cotransporter-2 Inhibitors With Fracture Risk in Older Adults With Type 2 Diabetes Sodium-Glucose Cotransporter-2 Inhibitors and Fracture Risk in Older Adults With Type 2 Diabetes, 2021-10-27

• Original Article: A Tool for Empirical Equipoise Assessment in Multi-group Comparative Effectiveness Research, 2019-05-27

• Fracture Risk After Initiating Canagliflozin: A Multi-Database Cohort Study, 2019-01-01

• Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions of disease states of gout, 2019-09-09

• Geographic patterns in patient demographics and insulin use in 18 countries, a global perspective from the multinational observational study assessing insulin use: understanding the challenges associated with progression of therapy (MOSAIc), 2015-09-09

• 2020 American College of Rheumatology Guideline for the Management of Gout, 2020-05-11

• Identification of smoking using Medicare data- A validation study of claims-based algorithms, 2016-01-13

• Tumor necrosis factor-a inhibitor use and the risk of incident hypertension in patients with rheumatoid arthritis, 2017-04-29

• Association between inflammation and systolic blood pressure in RA compared to patients without RA, 2018-06-01

• Validation of claims-based algorithms for identification of high-grade cervical dysplasia and cervical cancer, 2013-09-12

• Patterns of Bisphosphonates Utilization in Patients under Age 45 in a Large Cohort of Commercial Insurance Beneficiaries in the United States, 2015-01-22

• Knee osteonecrosis incidence from two real-world data sources, 2021-04-16

• Association of Sodium-Glucose Cotransporter-2 Inhibitors With Incident Atrial Fibrillation in Older Adults With Type 2 Diabetes Association of Sodium-Glucose Cotransporter-2 Inhibitors With Incident Atrial Fibrillation, 2022-10-11

• Patterns of Systemic Treatment for Psoriatic Arthritis in the United States: 2004-2015, 2018-03-23

• Association of Preoperative Opioid Use With Mortality and Short-term Safety Outcomes After Total Knee Replacement Association of Preoperative Opioid Use With Mortality and Safety Outcomes After Total Knee Replacement, 2019-07-31

• Assessment of Cardiovascular Risk in Older Patients with Gout Initiating Febuxostat versus Allopurinol: a Population-based Cohort Study, 2018-09-11

• Asymptomatic hyperuricemia and coronary flow reserve in patients with metabolic syndrome, 2018-06-20

• Giant cell arteritis treatment patterns and rates of serious infections, 2021-12-13

• The sequence of disease-modifying anti-rheumatic drugs: pathways to and predictors of tocilizumab monotherapy, 2021-01-14

• Should we target patients with autoimmune diseases for HPV vaccine uptake?, 2014-06-17

• Factors associated with initial or subsequent choice of biologic disease-modifying antirheumatic drugs for treatment of rheumatoid arthritis, 2017-07-05

• Risk of Non-Vertebral Fracture in Gout Compared to Rheumatoid Arthritis, 2021-10-11

• Comparative Fracture Risks among US Medicaid Enrollees with and without Systemic Lupus Erythematosus, 2019-06-05

• Risk of high-grade cervical dysplasia and cervical cancer in women with systemic inflammatory diseases: a population-based cohort study, 2014-03-11

• Active-comparator design and new-user design in observational studies, 2015-03-24

• Correction to: Association between inflammation and systolic blood pressure in RA compared to patients without RA, 2019-07-08

• Cardiovascular Risks in Older Patients with Gout Initiating Probenecid versus Allopurinol: a Cohort Study, 2018-03-06

• Comparative Rates of Serious Infections among Patients with Systemic Lupus Erythematosus Receiving Immunosuppressive Medications, 2016-08-25

• The Risk of Venous Thromboembolism in Patients with Rheumatoid Arthritis, 2014-06-04

• Dipeptidyl peptidase-4 inhibitors do not increase the risk of cardiovascular events in type 2 diabetes: a cohort study, 2014-10-14

• Clinical and health care use characteristics of patients newly prescribed allopurinol, febuxostat and colchicine for gout, 2014-06-04

• Comparative Effectiveness of Empagliflozin vs Liraglutide or Sitagliptin in Older Adults With Diverse Patient Characteristics Comparative Effectiveness of Empagliflozin vs Liraglutide or Sitagliptin in Older Adults, 2022-10-20

• Gout and Risk of Fracture in Women: A Prospective Cohort Study, 2016-08-23

• The association between lipid levels and major adverse cardiovascular events in rheumatoid arthritis compared to non-RA, 2015-04-25

• Use of osteoporosis medications after hospitalization for hip fracture: a cross-national study, 2015-02-03

• The Association Between Inflammation, Incident Heart Failure, and Heart Failure Subtypes in Patients with Rheumatoid Arthritis, 2022-12-12

• Clinical characteristics and medication uses among fibromyalgia patients newly prescribed amitriptyline, duloxetine, gabapentin or pregabalin, 2014-06-04

• Accuracy of identifying diagnosis of moderate to severe chronic kidney disease in administrative claims data, 2021-12-23

• Tofacitinib and risk of malignancy: results from the Safety of TofAcitinib in Routine care patients with Rheumatoid Arthritis (STAR-RA) Study, 2022-09-01

• Comparative safety and effectiveness of denosumab versus zoledronic acid in patients with osteoporosis: A cohort study, 2017-02-07

• Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions for disease elements in gout, 2018-05-30

• Assessing the Risk for Gout With Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes: A Population-Based Cohort Study, 2020-01-14

• An evaluation of longitudinal changes in serum uric acid levels and associated risk of cardio-metabolic events and renal function decline in gout, 2018-02-28

• Association of SGLT2 inhibitors with cardiovascular, kidney, and safety outcomes among patients with diabetic kidney disease: a meta-analysis, 2022-03-23

• Changes in Use of Disease Modifying Anti-Rheumatic Drugs for Rheumatoid Arthritis in the U.S. for the period 1983-2009, 2013-03-18

• Effects of xanthine oxidase inhibitors on cardiovascular disease in patients with gout: a cohort study, 2015-02-03

• Serious Infections among Adult Medicaid Beneficiaries with Systemic Lupus Erythematosus and Lupus Nephritis, 2015-03-05

• Dipeptidyl peptidase-4 inhibitors in type 2 diabetes may reduce the risk of autoimmune diseases: a population-based cohort study, 2014-06-11

• Risk of Venous Thromboembolism in Patients with Rheumatoid Arthritis Initiating Disease-Modifying Antirheumatic Drugs, 2014-12-20

• Racial Disparities in the Risk of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis as Urate-Lowering Drug Adverse Events in the US, 2016-03-31

• Validation of obesity-related diagnosis codes in claims data, 2021-08-18

• Association of geography and access to healthcare providers with long term prescription opioid use in Medicare patients with severe osteoarthritis: A cohort study, 2019-04-02

• The Risk of Atrial Fibrillation in Patients with Rheumatoid Arthritis, 2013-04-20

• Cancer screening rates in patients with rheumatoid arthritis: no different than the general population, 2012-05-11

• Racial/Ethnic Variation and Risk Factors for Allopurinol-Associated Severe Cutaneous Adverse Reactions: A Cohort Study, 2018-04-13

• Risk of cardiovascular outcomes in type 2 diabetes patients following addition of SGLT2 inhibitors versus sulfonylureas to baseline GLP-IRA therapy, 2020-12-11

• Cardiovascular Risks of Hydroxychloroquine vs. Methotrexate in Patients with Rheumatoid Arthritis, 2022-07-05

• Tofacitinib and risk of cardiovascular outcomes: results from the Safety of TofAcitinib in Routine care patients with Rheumatoid Arthritis (STAR-RA) study, 2022-01-13

• Assessment of coronary vascular function with cardiac PET in relation to serum uric acid, 2018-02-13

• Validation of Claims-Based Algorithms for Gout Flares, 2016-05-27

• Trends in Pharmacologic Treatment of Chronic Idiopathic Urticaria from 2016 to 2020, 2022-02-25

• Patterns of prescription opioid use before total hip and knee replacement among US Medicare enrollees, 2019-06-26

• Patient characteristics associated with use of TNF vs interleukin inhibitors as first-line biologic treatment for psoriatic arthritis, 2021-08-01

• Hydroxychloroquine lowers Alzheimer's disease and related dementias risk and rescues molecular phenotypes related to Alzheimer's disease, 2022-12-28

• Safety of Immunosuppressive Drugs in Pregnant Women with Systemic Inflammatory Diseases, 2014-03-31

• Real-world patient characteristics and use of disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis: a cross-national study, 2022-12-19

• Sociodemographics and epidemiology of serious infections requiring hospitalization among adults with systemic lupus erythematosus and lupus nephritis, 2000 to 2006, 2014-09-18

• Patterns and predictors of persistent opioid use following hip or knee arthroplasty, 2017-04-19

• Biologic Disease-Modifying Antirheumatic Drugs and Risk of High-grade Cervical Dysplasia and Cervical Cancer in Rheumatoid Arthritis: a Cohort Study, 2016-04-08

• Gout and the Risk of Non-vertebral Fracture, 2016-09-06

• Sodium-glucose cotransporter-2 inhibitors. vs. glucagon-like peptide 1 receptor agonists and the risk of cardiovascular outcomes in routine care patients with diabetes across categories of cardiovascular disease, 2021-09-28

• Risk of incident diabetes in patients with gout: a cohort study, 2015-03-26

• Trends in Utilization of Urate-Lowering Therapies Following the FDA's Boxed Warning to Febuxostat in the U.S., 2021-01-27

• Risk of High-Grade Cervical Dysplasia and Cervical Cancer in Women with Systemic Lupus Erythematosus Receiving Immunosuppressive Drugs, 2016-10-31

• Comparing Effectiveness and Safety of SGLT2 Inhibitors vs DPP-4 Inhibitors in Patients With Type 2 Diabetes and Varying Baseline HbA1cLevels Effectiveness and Safety of SGLT2 Inhibitors vs DPP-4 Inhibitors in Patients With Type 2 Diabetes, 2023-02-06

• Patterns and secular trends in use of immunomodulatory agents during pregnancy in women with rheumatologic conditions, 2016-02-10

• Use of biologic or targeted-synthetic disease-modifying anti-rheumatic drugs and risk of diabetes treatment intensification in patients with rheumatoid arthritis and diabetes mellitus, 2020-06-22

• Risk of Incident Atrial Fibrillation in Gout: a Cohort Study, 2015-08-31

• Risk of Hospitalized Infection and Initiation of Abatacept versus TNF Inhibitors among Patients with Rheumatoid Arthritis: a Propensity Score-Matched Cohort Study, 2019-11-29